John A Copelyn bought $25k of MNTK
director at Montauk Renewables, Inc.. 17,506 shares at an average of $1.45, traded May 11, 2026, filed May 13, 2026.
Score components
- +15RoleDirector
- +5Trade size$25k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950103-26-007157, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 11, 2026 | POpen-market purchase Common Stockindirect: See Footnote | +17,506 | $1.45 | $25k | 17,506 | May 13, 2026 |
Related signals
Other insiders at Montauk Renewables, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 53Moderate | Montauk Renewables, Inc. | Scott E Hill VP of Business Development | $1.3M 104,147 shares | -14% | |
| 54Moderate | Montauk Renewables, Inc. | Sean F McClain President and CEO | $726k 60,000 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.